Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,539,882 papers from all fields of science
Search
Sign In
Create Free Account
Gabapentin:MCnc:Pt:Ser/Plas:Qn
Known as:
Gabapentine:Massa concentratie:Moment:Serum of plasma:Kwantitatief
, Gabapentin [Mass/volume] in Serum or Plasma
, Gabapentine [Masse/Volume] Sérum/Plasma ; Numérique
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Neurontin
Plas
Serum
Unit of Mass Concentration
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Eficacia de la Gabapentina Preoperatoria Como Coadyuvante en el Manejo del Dolor Agudo Post Histerectomía Abdominal en Pacientes Oncológicas
Zárate Sevilla
,
Abraham Lincoln Nefi
2019
Corpus ID: 201958912
Introduction: Pain is an unpleasant sensory and emotional experience, postoperative pain is secondary to a primary or secondary…
Expand
2013
2013
Algoloji polikliniğine başvuran onkolojik hastalarda tedavi ve komplikasyon yönetimi: retrospektif değerlendirme
G. E. Kayhan
,
Nurcin Gulhas
,
Abdulvahap Aslan
,
Mahmut Durmuş
2013
Corpus ID: 70776229
Aim: In thist retrospective study, we evaluated pain intensity, pharmalogical therapy, patient satisfaction and rising…
Expand
2004
2004
Neuropatías dolorosas: fisiopatología y tratamiento
Alberto José Mimenza Alvarado
,
Juan Carlos Muñiz Álvarez
,
Bruno Estañol Vidal
,
José Francisco Téllez Zenteno
,
Guillermo García Ramos
2004
Corpus ID: 67988136
Objetivo. El presente trabajo pretende hacer una revision de los diversos mecanismos fisiopatologicos involucrados en la genesis…
Expand
2002
2002
Posible interacción gabapentina-fenitoína
A. S. Romero
,
J. A. D. Quintana
,
R. Delgado
,
Cándida Margarito Rangel
,
J. Andrés
2002
Corpus ID: 86793580
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE